Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils

Taken together, our results demonstrate high levels of Galectin-3 in the tumormicroenvironment of HGSC. High levels of Galectin-3 may induce production of reactiveoxygen species in ascites neutrophils in some patients. In turn, reactive oxygen species produced by neutrophils may modulate the NK cell anti-tumor immunity. Together, this study suggests further investigation to evaluate if a Galectin-3-targeting therapy may be used in ovarian cancer.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2024-12-20
DOI
https://doi.org/10.3389/fimmu.2024.1506236
Citations
4
Primary Topic
Galectins and Cancer Biology
Type
article
Field-Weighted Citation Impact
0.96

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils

Karin Christenson, Maria Lycke, Martina Sundqvist, Elin Bernson et al.
4 citations
Frontiers in Immunology
Galectins and Cancer Biology
0.96
article

Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils

Karin Christenson, Maria Lycke, Martina Sundqvist, Elin Bernson, Anneli Ivarsson, Karin Sundfeldt, Veronika Karlsson, Hakon Leffler, Ebba Stål, Emma Stoopendahl
article en
4 citations

Abstract

Taken together, our results demonstrate high levels of Galectin-3 in the tumormicroenvironment of HGSC. High levels of Galectin-3 may induce production of reactiveoxygen species in ascites neutrophils in some patients. In turn, reactive oxygen species produced by neutrophils may modulate the NK cell anti-tumor immunity. Together, this study suggests further investigation to evaluate if a Galectin-3-targeting therapy may be used in ovarian cancer.

Frontiers in ImmunologyVol. 15
Lund University (SE), University of Gothenburg (SE)
Åke Wiberg Stiftelse, Swedish Cancer Foundation, Cancerfonden, Stiftelserna Wilhelm och Martina Lundgrens, Svenska Sällskapet för Medicinsk Forskning, Vetenskapsrådet, Stiftelsen Assar Gabrielssons Fond, Svenska Läkaresällskapet, Reumatikerförbundet, Stiftelsen Mary von Sydows, född Wijk, donationsfond
Good health and well-being
Openalex Percentile: Top 23%
Galectins and Cancer Biology
0.96
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.